May-Jwan Tsai
Overview
Explore the profile of May-Jwan Tsai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang P, Lin S, Chang C, Tsai M, Lee D, Weng C
Sci Rep
. 2019 Nov;
9(1):15585.
PMID: 31666589
Dipeptidyl peptidase IV (DPP IV) is a surface glycoprotein that can degrade glucagon like pepetide-1 (GLP-1) by decreasing blood sugar. Herbal medicines for diabetic therapy are widely used with acceptable...
2.
Lin S, Chang C, Tsai M, Cheng H, Chen J, Leong M, et al.
Ther Adv Chronic Dis
. 2019 Sep;
10:2040622319875305.
PMID: 31555430
Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading enzyme, contains two forms and it can exert various physiological functions particular in controlling blood glucose through the action of...
3.
Lin S, Chang C, Hsu C, Tsai M, Cheng H, Leong M, et al.
Br J Pharmacol
. 2019 Aug;
177(6):1409-1423.
PMID: 31368509
Traditional chemotherapy is being considered due to hindrances caused by systemic toxicity. Currently, the administration of multiple chemotherapeutic drugs with different biochemical/molecular targets, known as combination chemotherapy, has attained numerous...
4.
Chiu W, Lin S, Chen Y, Tsai M, Leong M, Weng C
J Clin Med
. 2018 Oct;
7(10).
PMID: 30282915
Prodigiosin (PG) belongs to a family of prodiginines isolated from gram-negative bacteria. It is a water insoluble red pigment and a potent proapoptotic compound. This study elucidates the anti-tumor activity...
5.
Riyaphan J, Jhong C, Lin S, Chang C, Tsai M, Lee D, et al.
Molecules
. 2018 Sep;
23(9).
PMID: 30189596
The inhibition of α-glucosidase and α-amylase is a clinical strategy for the treatment of type II diabetes, and herbal medicines have been reported to credibly alleviate hyperglycemia. Our previous study...